Investors Purchase High Volume of Rockwell Medical Put Options (RMTI)
Rockwell Medical, Inc. (NASDAQ:RMTI) saw unusually large options trading on Friday. Stock traders bought 696 put options on the stock. This is an increase of approximately Infinity compared to the average volume of 0 put options.
Rockwell Medical (RMTI) opened at $6.74 on Monday. Rockwell Medical has a twelve month low of $5.01 and a twelve month high of $8.98.
Rockwell Medical (NASDAQ:RMTI) last released its earnings results on Wednesday, November 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of ($0.10). The business had revenue of $14.63 million for the quarter, compared to analyst estimates of $13.33 million. Rockwell Medical had a negative return on equity of 46.63% and a negative net margin of 39.28%. The company’s revenue for the quarter was up 14.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.09) earnings per share. sell-side analysts expect that Rockwell Medical will post -0.44 EPS for the current fiscal year.
Several research analysts have commented on the company. Zacks Investment Research lowered Rockwell Medical from a “hold” rating to a “sell” rating in a research report on Tuesday, August 15th. BidaskClub raised Rockwell Medical from a “sell” rating to a “hold” rating in a research report on Wednesday, August 23rd. Finally, Ifs Securities assumed coverage on Rockwell Medical in a research report on Monday, August 14th. They set a “strong-buy” rating and a $11.00 price target on the stock.
Large investors have recently added to or reduced their stakes in the company. Raymond James Financial Services Advisors Inc. purchased a new stake in shares of Rockwell Medical in the third quarter valued at approximately $107,000. KCG Holdings Inc. purchased a new stake in shares of Rockwell Medical in the first quarter valued at approximately $111,000. PNC Financial Services Group Inc. boosted its stake in shares of Rockwell Medical by 1,725.7% in the second quarter. PNC Financial Services Group Inc. now owns 15,245 shares of the company’s stock valued at $121,000 after buying an additional 14,410 shares in the last quarter. UBS Asset Management Americas Inc. boosted its stake in shares of Rockwell Medical by 38.3% in the second quarter. UBS Asset Management Americas Inc. now owns 19,843 shares of the company’s stock valued at $157,000 after buying an additional 5,500 shares in the last quarter. Finally, Private Advisor Group LLC purchased a new stake in shares of Rockwell Medical in the second quarter valued at approximately $182,000. 21.72% of the stock is currently owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY NOTICE: “Investors Purchase High Volume of Rockwell Medical Put Options (RMTI)” was first reported by Daily Political and is the property of of Daily Political. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of United States and international copyright and trademark legislation. The correct version of this piece of content can be accessed at https://www.dailypolitical.com/2017/11/12/investors-purchase-high-volume-of-rockwell-medical-put-options-rmti.html.
Rockwell Medical Company Profile
Rockwell Medical, Inc (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process.
Receive News & Ratings for Rockwell Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.